EXPD vs TRDA · P/E 26, rev $10.60B vs P/E 12, rev $210.8M
Expeditors International of Washington, Inc. (EXPD) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the EXPD and TRDA stock pages for the full models.
Not investment advice.